GlassScriptPhysician profile
Janie Pitts
NPI 1679027254
$253.28
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $253.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $43.98 | 2021 | |
| Corium, LLC | $43.02 | 2021 | |
| Sobi, INC | $25.99 | 2021 | |
| Pfizer INC. | $25.63 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.94 | 2021 | |
| Neos Therapeutics, LP | $17.92 | 2021 | |
| Boston Scientific Corporation | $15.26 | 2021 | |
| Abbvie INC. | $13.59 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $13.28 | 2021 | |
| Kaleo, INC. | $12.52 | 2021 | |
| Glaxosmithkline, LLC. | $12.23 | 2021 | |
| Seqirus USA INC | $11.92 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janie Pitts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.